Tuesday, July 12, 2016
Pharmaceutical Rapid Microbiology Testing Market : Global Industry Information, Market Needs and Strategies 2016-2023
Do you like this story?
According to the latest report published by Credence Research,
Inc. “Pharmaceutical Rapid Microbiology Testing Market –
(Technology Type – Immunology based Methods, Nucleic acid based amplification
tests, Mass Spectrometry based Methods, Flow Cytometry based Methods,
Growth-based detection technologies, and Biochemical Tests; Application – Raw
Material testing, In-Process testing, Microbial limit testing, Bioburden
assessment, Process water testing, environment monitoring and sterility
testing): Market Growth, Future Prospects and Competitive Analysis,
2016-2022,” The Market was valued at USD 3.4 Bn in 2015, and is expected
to reach USD 6.2 Bn by 2022, expanding at a CAGR of 7.3% from 2016 to 2022.
Market Insights :
Rapid microbiological tests are gaining momentum in the global
market as a reliable and cost-effective method to track and monitor all types
of microorganisms in pharmaceutical application as well as in other industrial
settings. In addition, rapid microbiology tests offer faster and more accurate
methods to assist in the rapid detection of microbes and early diagnosis, thus
saving cost and inventory. North America held the largest regional market,
accounting for the market share of over 36% in 2015, and is anticipated to
dominate the global rapid microbiology tests market during the forecast period
2016 to 2022. Large numbers of market-focused players providing wider
range of product portfolio are the key to growth of the North America
region. Asia Pacific is expected to grow at a highest growth rate during the
focus period, due to increase in the number of laboratories in these regions
and up gradation of existing ones for automation of various instrumentation
systems. Moreover, the market is wide open for advancing rapid diagnostic
technologies to improve the turnaround time of the tests as compared to the
conventional microbiology testing methods.
Browse the full report Pharmaceutical Rapid Microbiology
Testing Market: Growth, Future Prospects and Competitive Analysis, 2016-2022
report at http://www.credenceresearch.com/report/pharmaceutical-rapid-microbiology-testing-market
Among the technology types, nucleic acid amplification technique
held the largest share in the rapid microbiology tests in the pharmaceutical
industry market due to its low cost and high efficacy. Moreover, the wide
applications of nucleic acid amplification testing would further fuel the
market growth in the coming years. Growth based detection technologies are
anticipated to grow at a highest growth rate during the forecast period due to its
faster turnaround time and accuracy in the detection of the microbes.
The sterility testing application held the largest share in the
global rapid microbiology tests in pharmaceutical market due its wide
application in the final drug product and other applications. Process water
testing is anticipated to witness the highest growth in the global rapid
microbiology tests in the pharmaceutical industry market during the forecast
period of 2016 to 2022.
About Us:
Credence Research is a worldwide industry research and
counseling firm that serves driving organizations, governments, non legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm
extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Subscribe to:
Post Comments (Atom)
0 Responses to “Pharmaceutical Rapid Microbiology Testing Market : Global Industry Information, Market Needs and Strategies 2016-2023”
Post a Comment